Compare NeoGenomics Inc. Common Stock (NEO) vs OUTFRONT Media Inc. Common Stock (OUT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs OUTFRONT Media Inc. Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while OUTFRONT Media Inc. Common Stock trades at $29.55 (market cap $5.33B). The key difference: OUTFRONT Media Inc. Common Stock is far larger — about 2.5× NeoGenomics Inc. Common Stock's market cap, and OUTFRONT Media Inc. Common Stock pays a 4.06% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and OUTFRONT Media Inc. Common Stock for 0 Days on average.
| NEO | OUT | |
|---|---|---|
Market Cap | $2.14B | $5.33B |
Volume | 2,228,400 | 1,197,618 |
Sector | Health | Real Estate |
52-Week High | $19.91 | $33.90 |
52-Week Low | $7.19 | $17.08 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.44B | $9.43B |
Dividend Yield | — | 4.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About OUTFRONT Media Inc. Common Stock
OUTFRONT Media Inc. is a US out-of-home media REIT that provides advertising space on billboard and transit displays across major markets in US and Canada.
Read more on OUT →
